APA (7th ed.) Citation

Guo, Z., Sa, R., Zhao, D., Li, S., Guo, H., Zhu, L., & Chen, G. Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: A pilot study. BMC.

Chicago Style (17th ed.) Citation

Guo, Zhiliang, Rula Sa, Daqiang Zhao, Songxia Li, Hui Guo, Lan Zhu, and Gang Chen. Daratumumab Followed by Tocilizumab for Treatment of Late Antibody-mediated Rejection in Renal Transplant Recipients with High or Moderate Levels of De Novo Donor-specific Antibodies: A Pilot Study. BMC.

MLA (9th ed.) Citation

Guo, Zhiliang, et al. Daratumumab Followed by Tocilizumab for Treatment of Late Antibody-mediated Rejection in Renal Transplant Recipients with High or Moderate Levels of De Novo Donor-specific Antibodies: A Pilot Study. BMC.